These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 36652141
1. Radiomics signatures based on contrast-enhanced CT for preoperative prediction of the Ki-67 proliferation state in gastrointestinal stromal tumors. Liu M, Bian J. Jpn J Radiol; 2023 Jul; 41(7):741-751. PubMed ID: 36652141 [Abstract] [Full Text] [Related]
3. Prediction of the Ki-67 expression level and prognosis of gastrointestinal stromal tumors based on CT radiomics nomogram. Feng Q, Tang B, Zhang Y, Liu X. Int J Comput Assist Radiol Surg; 2022 Jun; 17(6):1167-1175. PubMed ID: 35195831 [Abstract] [Full Text] [Related]
4. Predictive Value of a Radiomics Nomogram Model Based on Contrast-Enhanced Computed Tomography for KIT Exon 9 Gene Mutation in Gastrointestinal Stromal Tumors. Wei Y, Lu Z, Ren Y. Technol Cancer Res Treat; 2023 Jun; 22():15330338231181260. PubMed ID: 37296525 [Abstract] [Full Text] [Related]
5. Radiomics Nomogram Based on Contrast-enhanced CT to Predict the Malignant Potential of Gastrointestinal Stromal Tumor: A Two-center Study. Song Y, Li J, Wang H, Liu B, Yuan C, Liu H, Zheng Z, Min F, Li Y. Acad Radiol; 2022 Jun; 29(6):806-816. PubMed ID: 34238656 [Abstract] [Full Text] [Related]
6. Prediction of Ki-67 expression in gastrointestinal stromal tumors using radiomics of plain and multiphase contrast-enhanced CT. Liu Y, He C, Fang W, Peng L, Shi F, Xia Y, Zhou Q, Zhang R, Li C. Eur Radiol; 2023 Nov; 33(11):7609-7617. PubMed ID: 37266658 [Abstract] [Full Text] [Related]
7. Development of a CT radiomics nomogram for preoperative prediction of Ki-67 index in pancreatic ductal adenocarcinoma: a two-center retrospective study. Li Q, Song Z, Li X, Zhang D, Yu J, Li Z, Huang J, Su K, Liu Q, Zhang X, Tang Z. Eur Radiol; 2024 May; 34(5):2934-2943. PubMed ID: 37938382 [Abstract] [Full Text] [Related]
8. Prediction of recurrence-free survival and adjuvant therapy benefit in patients with gastrointestinal stromal tumors based on radiomics features. Wang FH, Zheng HL, Li JT, Li P, Zheng CH, Chen QY, Huang CM, Xie JW. Radiol Med; 2022 Oct; 127(10):1085-1097. PubMed ID: 36057930 [Abstract] [Full Text] [Related]
14. Computed tomography-based radiomics model for discriminating the risk stratification of gastrointestinal stromal tumors. Zhang L, Kang L, Li G, Zhang X, Ren J, Shi Z, Li J, Yu S. Radiol Med; 2020 May; 125(5):465-473. PubMed ID: 32048155 [Abstract] [Full Text] [Related]
20. Radiomics analysis of contrast-enhanced computerized tomography for differentiation of gastric schwannomas from gastric gastrointestinal stromal tumors. Zhang C, Wang C, Mao G, Cheng G, Ji H, He L, Yang Y, Hu H, Wang J. J Cancer Res Clin Oncol; 2024 Feb 09; 150(2):87. PubMed ID: 38336926 [Abstract] [Full Text] [Related] Page: [Next] [New Search]